NUVB - Nuvation Bio Inc
This page shows which of the focused investors we track hold NUVB and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 3 managers with an aggregate reported value of $25.08M, which is 0.00% of the combined portfolio.
As of Q1 2026, 3 tracked institutional managers held NUVB (Nuvation Bio Inc) with an aggregate reported value of $25.08M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades NUVB — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- NUVB
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.66% | New | 4,539,800 | $19.48M |
| 2 | David Abrams - Abrams Capital Management | 0.12% | Reduce -66.7% | 1,270,504 | $5.45M |
| 3 | David Einhorn - Greenlight Capital | 0.00% | - | 34,995 | $150.13K |
Loading holder history for NUVB…